Team
The LUMC-led consortium includes various institutes in Europe, Africa, United States, and Australia.
Coordinator:
Leiden University Medical Center, The Netherlands - LUMC
Partners:
Aberystwyth University, United Kingdom - AU
BiOMViS Srl, Italy - BiOMViS
Lambaréné Medical Research Centre, Gabon - CERMEL
Genos Glycoscience Research Laboratory, Croatia - GENOS
Barcelona Institute for Global Health, Spain - ISGLOBAL
James Cook University, Australia - JCU
LINQ management GmbH, Germany - LINQ
Swiss Tropical and Public Health Institute, Switzerland – Swiss TPH
Texas Tech University System, United States - TTUS
Uganda National Health Research Organisation, Uganda - UNHRO
Wageningen University, The Netherlands - WU
WORMVACS2.0 is supported by mRNA Access, powered by Moderna.
Scientific Advisory Board
Prof Dr Faith Osier
Chair in Malaria Immunology and Vaccinology, Department of Life Sciences - Faculty of Natural Sciences, Imperial College London
Prof Dr Rick Maizels
Professor of Parasitology at the Wellcome Centre for Integrative Parasitology in the University of Glasgow's Institute of Infection, Immunity and Inflammation
Prof Dr Michael Good
Head of Laboratory of Vaccines for the Developing World, Institute for Glycomics, Griffith University on the Gold Coast, Queensland